Scotté, Florian http://orcid.org/0000-0002-7433-3428
Schwartzberg, Lee
Iihara, Hirotoshi
Aapro, Matti
Gralla, Richard
Hesketh, Paul J.
Jordan, Karin
Chow, Ronald
Herrstedt, Jørn
Article History
Accepted: 1 December 2023
First Online: 20 December 2023
Change Date: 12 February 2024
Change Type: Update
Change Details: The correct family name should be: Iihara
Declarations
:
: Florian Scotté declares he has received honoraria from Sanofi, Sandoz, Roche, MSD, Prostrakan, Leo Pharma, Janssen, AMGEN, Pierre Fabre Oncologie, Vifor Pharma, Arrow, Pfizer, BMS, Bayer, Thermo Fisher, Pharmanovia, Gilead, Viatris, and Helsinn.Lee Schwartzberg declares he has received honoraria from Helsinn, GlaxoSmithKline, and Pfizer.Hirotoshi Iihara declares that he has received personal fees from Taiho, Chugai, Yakult, Astellas, Eli Lilly, Daiichi Sankyo, AstraZeneca, Nippon Kayaku, Ono, and Nippon Boehringer Ingelheim and consulting fees for their institution from Taiho and Eisai outside the submitted work.Matti Aapro declares the following interests relevant to this manuscript: has received honoraria from Berlin-Chemie, Fosun, Helsinn Healthcare SA, Juniper Biologics, Knight Therapeutics, Mundipharma International Limited, and Vifor Pharma.Richard Gralla declares the following interests relevant to this manuscript: has received honoraria from Fosun, Helsinn Healthcare SA, Juniper Biologics, Knight Therapeutics, Mundipharma International Limited, and Vifor Pharma.Paul J Hesketh declares that he has no financial interests.Karin Jordan reports personal fees as an invited speaker from Amgen, Art Tempi, Helsinn Healthcare SA, Hexal, Med Update GmbH, MSD, Mundipharma, Onkowissen, Esteve, Roche, Shire (Takeda), and Vifor; personal fees for advisory board membership from Amgen, AstraZeneca, BD Solutions, Hexal, Karyopharm, and Voluntis; and personal fees as author for UpToDate.Ronald Chow declares that he has no financial interests.Jørn Herrstedt declares he has received honoraria from Pharmathen S.A.The other authors have no relevant financial or non-financial interests to declare.